CrossrefInfokarte
Effects of Evogliptin and Dapagliflozin on Bone and Glucose Metabolism in Postmenopausal Women with Type 2 Diabetes: A Multicenter Randomized Exploratory Clinical Trial
Diabetes, Metabolic Syndrome and Obesity · 2026-10 · Volume 19 · 1-14
DOI: 10.2147/dmso.s618336 ↗Abstract
Kein Abstract verfügbar.
EUVIMED